Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
KRAS inhibitor
Echinocandin antifungal
Fluoroquinolone; topoisomerase IV and bacterial...
NSAID; COX-2 inhibitor.
Non-nucleoside RT inhibitor.
Methylxanthine; PDE inhibitor, A1/2 adenosine a...
Semi-synthetic avermectin; GABA potentiator.
Tetracycline; protein translation inhibitor, MM...
AMPK activator, D1-4, 5-HT1A/2/3/6/7, M1-5 mACh...
Endogenous peptide, involved in paracrine and a...
Alkaloid found in Sinomenium; acid-sensing ion ...
Curcumin derivative; DNMT1 and α-amylase inhib...
Iron chelator.
SERT inhibitor, potential voltage-gated K+ chan...
Proteasome inhibitor.
Opioid peptide; δOR agonist.
DOT1L HMT inhibitor.
Polyphenol found in Gossypium; calcineurin and ...
Endogenous APP peptide cleavage product, primar...
Alternaria mycotoxin which may be found in food...